Topical Lipolysis Composition for Non-Invasive Fat Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reducing localized adipose tissue, such as liposuction and phosphatidylcholine injections, are invasive, painful, expensive, and have significant adverse effects, while topical treatments are ineffective or have high failure rates due to poor skin penetration.
Innovation Solution
A topical composition combining highly purified phosphatidylcholine with sodium deoxycholate and water forms a stable mixed micelle preparation for transdermal delivery, using a nanostructured lipid carrier to penetrate the skin and dissolve fat cells non-invasively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If surgical methods like liposuction are used to remove fat, then fat removal effectiveness is improved, but patient safety and comfort deteriorate due to significant adverse events, pain, and recovery time
Solution Approach 1:
The patent replaces the mechanical surgical system (cannula insertion, suction, physical fat removal) with a chemical system (detergent composition application). The detergent composition chemically emulsifies and breaks down fat cells through saponification and micelle formation, eliminating the need for mechanical disruption and suction procedures that cause tissue trauma, bleeding, and anesthesia requirements.
Solution Approach 2:
The patent changes the fundamental mechanism of fat removal from mechanical extraction to chemical transformation. By applying detergent compositions that alter the chemical structure of fat cells (converting triglycerides to soap and glycerol through hydrolysis), the system achieves fat removal without the physical trauma inherent in surgical methods, thereby reducing adverse events while maintaining effectiveness.
2Object-affected harmful factors
If topical treatments are used instead of surgery, then patient safety and comfort are improved, but clinical efficacy deteriorates as existing topical treatments lack proven effectiveness
Solution Approach 1:
The patent employs a composite detergent composition containing multiple active ingredients (anionic surfactants, non-ionic surfactants, chelating agents, and auxiliary compounds) that work synergistically. This composite formulation provides both the clinical efficacy previously only achievable through surgery and the safety profile of non-invasive topical treatment, overcoming the limitations of simple topical applications.
Solution Approach 2:
The detergent composition acts as an intermediary substance that facilitates fat cell breakdown through chemical emulsification. The surfactants in the composition mediate the interaction between water-soluble and fat-soluble components, enabling effective fat removal through topical application without requiring surgical intervention, thus bridging the gap between safety and efficacy.
3Productivity
If injectable phosphatidylcholine formulations are used, then fat reduction is achieved, but localized burning sensations, erythema, and other side effects occur
Solution Approach 1:
The patent uses a topical application that acts locally and temporarily at the treatment site, being rinsed or absorbed without systemic circulation. This disposable-like approach at the application site eliminates the sustained localized irritation and inflammatory responses associated with injectable formulations that remain in tissue for extended periods, reducing burning sensations and erythema while maintaining fat reduction capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces subcutaneous fat deposits without surgery, minimizing adverse effects and recovery time, with demonstrated clinical efficacy in reducing localized fat accumulations.
Implementation Method 1
administration is percutaneous, i.e., absorption through the skin from topical application at or proximate to localized adipose tissue
Implementation Method 2
The compositions include detergents and can also include other agents such as anti-inflammatory agents, analgesics, dispersion or anti-dispersion agents
Data Source
AI summary
A method for non-surgically reducing localized adipose tissue in a patient is provided. The method comprises topically administering to a site at or proximate adipose tissue, with massage at the site of administration, a composition comprising: at least one biologically compatible pharmacologically active detergent selected from the group consisting of a lipophilic detergent, a hydrophilic detergent, an ionic detergent, a non-ionic detergent, a zwitterionic detergent, a glyceride and a bile acid or salt thereof in a concentration ranging from about 0.5% to about 30% by wt of the composition and at least one phospholipid. In one embodiment, a novel composition comprising deoxycholic acid or a salt thereof at a concentration ranging from about 0.5% to about 30% by wt, and phosphatidylcholine at a concentration ranging from about 0.1% to about 2% by wt, in a cream base is also provided.